Spinal abnormalities in neurofibomatosis type 1
Spinal abnormalities in neurofibomatosis type 1
批准号:
7590467
负责人:
DAVID H. VISKOCHIL
金额:
$28.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-07-01 至 2011-03-31
关键词:
Academic Medical CentersAddressAreaBone DensityBone ResorptionBritish ColumbiaChildClinicalClinical ManagementClinical ResearchDefectDeformityDevelopmental Bone DiseasesDiseaseDysplasiaFutureGoalsHereditary DiseaseIncidenceIndividualMagnetic Resonance ImagingMeasuresMeningoceleMuscleNatural HistoryNeurofibromatosesNeurofibromatosis 1OutcomeOutcome StudyPathogenesisPathological DilatationPatientsPediatric HospitalsPeripheralPrognostic FactorRecording of previous eventsRecruitment ActivityRotationScallopScreening procedureSpinalSpinal CanalSpinal CordTestingTherapeutic Clinical TrialThickUniversitiesUtahVertebral columnWingX-Ray Computed Tomographybonebone healthbone masscohortcrosslinkimprovedindexinglong boneneurofibromaprepubertyprognostic indicatorrib bone structurescoliosisskeletal abnormalityspine bone structuretoolurinaryvertebra body
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Neurofibromatosis type 1 (NF1) is a common genetic disorder with a high degree of variability of clinical
expression, including skeletal abnormalities in over 1/3 of patients. This disorder is associated with spinal
abnormalities, long bone dysplasia, and sphenoid wing dysplasia. These osseous manifestations are
unpredictable, and the pathogenesis, natural history, and clinical outcome remain relatively obscure. The
spinal abnormalities are varied and include scoliosis (common and dystrophic forms), neurofibromas,dural
ectasias, meningoceles, and vertebral defects. The primary objectives of this clinical study are to determine
the incidence and clinical history of NF1-related spinal abnormalities in a prepubertal cohort of 120 children
with NF1 over 3 years. Secondary objectives are to determine the efficacy of various radiographic screening
tools as predictors for dystrophic scoliosis. These goals will be accomplished in 3 specific aims. Aim 1 is to
identify associations of spinal cord dural ectasias, spinal neurofibromas,and meningoceles with dysplastic
osseous abnormalities and dystrophic scoliosis. Spine radiographs and MRI will be used to test the
hypothesis that NF1 patients with certain manifestations are more likely to develop dystrophic scoliosis. Aim
2 is to define the clinical history and short-term outcome of dystrophic scoliosis and spine abnromalities with
respect to various radiographic indices. It tests the hypothesis that there are quantitative differences in
vertebral scalloping and spinal canal and vertebral body cross-sectional areas when there is an associated
additional dystrophic abnormality, and these differences are prognostic indicators for dystrophic scoliosis.
Aim 3 is to determine the differences in bone health variables between NF1 patients and individuals without
NF1, and between NF1 individuals without dystrophic scoliosis versus NF1 individuals who develop
dystrophic scoliosis. Dual energy x-ray absorptiometry (DXA) and peripheral quantitative computerized
tomography (pQCT) will be used to test the hypothesis that there-are subtle bone abnormalities of bone
mineral density, bone area, bone mass, muscle-to-bone ratios, and cortical thickness in NF1. Urinary
Dyridinium cross-links will be measured to detect differences in bone resorption. Spinal abnormalities in NF1
are not well understood, and dystrophic scoliosis is a highly morbid condition. This proposal will identify
variables in patients with NF1 as prognostic factors for dystrophic scoliosis to improve clinical management.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: MPS II PATIENTS RECEIVING ENZYME REPLACEMENT THERAPY
-
批准号:7718513
-
项目类别:
-
资助金额:$0.07万
-
财政年份:2008
-
负责人:DAVID H. VISKOCHIL
-
依托单位:
CLINICAL GENETICS RESEARCH PROGRAM
-
批准号:7718483
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2008
-
负责人:DAVID H. VISKOCHIL
-
依托单位:
CLINICAL GENETICS RESEARCH PROGRAM
-
批准号:7604941
-
项目类别:
-
资助金额:$7.67万
-
财政年份:2007
-
负责人:DAVID H. VISKOCHIL
-
依托单位:
MPS II PATIENTS RECEIVING ENZYME REPLACEMENT THERAPY
-
批准号:7604971
-
项目类别:
-
资助金额:$0.44万
-
财政年份:2007
-
负责人:DAVID H. VISKOCHIL
-
依托单位:
MPS II PATIENTS RECEIVING ENZYME REPLACEMENT THERAPY
-
批准号:7376481
-
项目类别:
-
资助金额:$1.67万
-
财政年份:2006
-
负责人:DAVID H. VISKOCHIL
-
依托单位:
Spinal abnormalities in neurofibomatosis type 1
-
批准号:7409973
-
项目类别:
-
资助金额:$27.75万
-
财政年份:2006
-
负责人:DAVID H. VISKOCHIL
-
依托单位:
Spinal abnormalities in neurofibomatosis type 1
-
批准号:7805420
-
项目类别:
-
资助金额:$29.07万
-
财政年份:2006
-
负责人:DAVID H. VISKOCHIL
-
依托单位:
Spinal abnormalities in neurofibomatosis type 1
-
批准号:7253117
-
项目类别:
-
资助金额:$34.01万
-
财政年份:2006
-
负责人:DAVID H. VISKOCHIL
-
依托单位:
Spinal abnormalities in neurofibomatosis type 1
-
批准号:7038788
-
项目类别:
-
资助金额:$37.92万
-
财政年份:2006
-
负责人:DAVID H. VISKOCHIL
-
依托单位:
RECOMBINANT HUMAN ALPHA-L IDURONIDASE IN PATIENTS WITH MUCOPOLYSACCHARIDOSIS I
-
批准号:7201409
-
项目类别:
-
资助金额:$6.12万
-
财政年份:2005
-
负责人:DAVID H. VISKOCHIL
-
依托单位:
SKELETAL PHENOTYPING AND MUTATION SCREENING IN NEUROFIBROMATOSIS
-
批准号:7201438
-
项目类别:
-
资助金额:$0.65万
-
财政年份:2005
-
负责人:DAVID H. VISKOCHIL
-
依托单位:
Somatic mutation analysis of neurofibromatosis Type 1
-
批准号:7044759
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2004
-
负责人:DAVID H. VISKOCHIL
-
依托单位:
Extension trial for enzyme replacement therapy in MPS 1
-
批准号:7044757
-
项目类别:
-
资助金额:$5.85万
-
财政年份:2004
-
负责人:DAVID H. VISKOCHIL
-
依托单位:
SOMATIC MUTATION ANALYSIS OF NEUROFIBROMATOSIS TYPE I
-
批准号:6304910
-
项目类别:
-
资助金额:$0.16万
-
财政年份:1999
-
负责人:DAVID H. VISKOCHIL
-
依托单位:
SOMATIC MUTATION ANALYSIS OF NEUROFIBROMATOSIS TYPE I
-
批准号:6114822
-
项目类别:
-
资助金额:$2.81万
-
财政年份:1998
-
负责人:DAVID H. VISKOCHIL
-
依托单位:
SOMATIC MUTATION ANALYSIS OF NEUROFIBROMATOSIS TYPE I
-
批准号:6425961
-
项目类别:
-
资助金额:$0.16万
-
财政年份:1998
-
负责人:DAVID H. VISKOCHIL
-
依托单位:
SOMATIC MUTATION ANALYSIS OF NEUROFIBROMATOSIS TYPE I
-
批准号:6218415
-
项目类别:
-
资助金额:$0.16万
-
财政年份:1998
-
负责人:DAVID H. VISKOCHIL
-
依托单位:
SOMATIC MUTATION ANALYSIS OF NEUROFIBROMATOSIS TYPE I
-
批准号:6245927
-
项目类别:
-
资助金额:$2.15万
-
财政年份:1997
-
负责人:DAVID H. VISKOCHIL
-
依托单位:
SOMATIC MUTATION ANALYSIS OF NEUROFIBROMATOSIS TYPE I
-
批准号:6276057
-
项目类别:
-
资助金额:$2.66万
-
财政年份:1997
-
负责人:DAVID H. VISKOCHIL
-
依托单位:
MOLECULAR GENETICS OF NEUROFIBROMATOSIS TYPE 1
-
批准号:3084595
-
项目类别:
-
资助金额:$8.26万
-
财政年份:1991
-
负责人:DAVID H. VISKOCHIL
-
依托单位:
海外基金